Applied Biosystems Announces Internet Availability of Its 2008 Annual Report on Form...

Applied Biosystems Announces Internet Availability of Its 2008 Annual Report on Form 10-K

NORWALK, Conn.--(Business Wire)--
Applied Biosystems Inc. (NYSE: ABI) today announced the Internet
availability of its 2008 Annual Report on Form 10-K. The Annual Report
on Form 10-K has been filed with the U.S. Securities and Exchange
Commission and may be accessed through the Company's investor
relations website at http://ir.appliedbiosystems.com. Applied
Biosystems' shareholders and other interested parties may obtain hard
copies of the Company's complete audited financial statements for the
fiscal year ending June 30, 2008 free of charge by following the
instructions provided on the Company's website.

About Applied Biosystems Inc.

Applied Biosystems Inc. (formerly known as Applera Corporation) is
a global leader in the development and marketing of instrument-based
systems, consumables, software, and services for academic research,
the life science industry and commercial markets. Driven by its
employees' belief in the power of science to improve the human
condition, the company commercializes innovative technology solutions
for DNA, RNA, protein and small molecule analysis. Customers across
the disciplines of academic and clinical research, pharmaceutical
research and manufacturing, forensic DNA analysis, and agricultural
biotechnology use the company's tools and services to accelerate
scientific discovery, improve processes related to drug discovery and
development, detect potentially pathogenic microorganisms, and
identify individuals based on DNA sources. Applied Biosystems has a
comprehensive service and field applications support team for a global
installed base of high-performance genetic and protein analysis
solutions. Applied Biosystems Inc. is headquartered in Norwalk, CT. On
June 12, 2008, Applera Corporation and Invitrogen Corporation (NASDAQ:
IVGN) announced that their Boards of Directors had approved a
definitive merger agreement under which Invitrogen will acquire all of
the outstanding shares of Applied Biosystems stock. The merger is
subject to customary closing conditions and is targeted to close in
the fall of 2008. Further information regarding the merger will be
provided in a joint proxy statement/prospectus to be mailed to
shareholders of both companies. Investors and security holders are
urged to read this document in its entirety because it will contain
important information about the companies and the proposed
transaction. Information about Applied Biosystems, including reports
and other information filed by the company with the Securities and
Exchange Commission, is available at http://www.appliedbiosystems.com.
All information in this news release is as of the date of the release,
and Applied Biosystems does not undertake any duty to update this
information unless required by law.

Applied Biosystems Inc.
Peter Dworkin, 650-554-2479 (Investors and Media)
peter.dworkin@appliedbiosystems.com

Copyright Business Wire 2008